High blood pressure does appear to raise the risk of developing kidney stones, and the connection is stronger than many people realize. A prospective study of over 500 men found that those with hypertension were roughly twice as likely to develop stones over the follow-up period compared to men with normal blood pressure.1Journal of Hypertension. A prospective study of hypertension and the incidence of kidney stones in men The relationship involves more than coincidence: hypertension changes how the kidneys handle calcium, acid, and natural stone-inhibiting compounds, creating an internal chemistry that favors stone formation.
How Strong Is the Link Between Hypertension and Kidney Stones?
Multiple lines of evidence point the same direction. In that prospective study of men tracked over time, about 17% of hypertensive men developed kidney stones compared with roughly 8.5% of men with normal blood pressure. The doubled risk held even after accounting for age and body weight.1Journal of Hypertension. A prospective study of hypertension and the incidence of kidney stones in men Larger population data reinforces this. A cross-sectional analysis of the U.S. National Health and Nutrition Examination Survey found that people with hypertension had about a 36% higher prevalence of kidney stones after adjusting for other risk factors. That same study applied a genetic technique called Mendelian randomization, which uses inherited gene variants to test whether one condition causally influences another, and found evidence pointing toward hypertension as a genuine cause rather than just a fellow traveler.2PubMed. Association between hypertension and kidney stones: a cross-sectional analysis from NHANES and Mendelian randomization
The genetic angle has been explored further. A recent large-scale analysis of genetic data confirmed a modest but statistically significant positive genetic correlation between kidney stones and hypertension, with a correlation coefficient of about 0.14 to 0.19.3PubMed Central. The Genetic Associations Between Kidney Stones, Obesity, Type 2 Diabetes, and Hypertension That number is not huge, but it tells us the two conditions share some underlying genetic architecture. You are not just unlucky if you have both. There is biology pulling both conditions in the same direction.
How High Blood Pressure Changes Your Kidney Chemistry
The kidneys of someone with hypertension handle certain minerals differently, and those differences add up to a stone-friendly environment. The most direct change involves calcium. People with high blood pressure tend to excrete more calcium in their urine than people with normal blood pressure. One multi-ethnic population study found that a 20 mmHg higher systolic blood pressure independently predicted higher daily urinary calcium.4Journal of Human Hypertension. Urinary calcium excretion, sodium intake and blood pressure in a multi-ethnic population: results of the Wandsworth Heart and Stroke Study More calcium in the urine means more raw material for calcium-based stones, which account for the vast majority of kidney stones.
Researchers have proposed two main explanations for this calcium leak. One is that hypertension comes with a primary defect in how the kidney tubules reabsorb calcium, so more of it spills into the urine. The other is that hypertension causes the body’s central blood volume to expand, which signals the kidneys to dump extra calcium.5PubMed. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism Either way, the kidney lets go of calcium it would normally keep, and the downstream consequence is the same: a urine environment that is oversaturated with calcium.
Beyond calcium, hypertension also shifts urinary acid-base balance. Kidney stone formers who have essential hypertension tend to produce urine that is more acidic and contains less citrate than stone formers without hypertension.6Nephrology Dialysis Transplantation. Increased acid excretion in kidney stone formers with essential hypertension Citrate acts as a natural inhibitor of stone crystallization. When citrate drops and acidity rises, the urine becomes a more hospitable place for both uric acid stones and calcium oxalate stones to form. This combination of excess calcium, low citrate, and low pH is something of a perfect storm.
The Salt Problem Connecting Both Conditions
High salt intake is a well-known driver of elevated blood pressure, but it also independently pushes urinary calcium upward. Studies show that for every increase in sodium excretion, urinary calcium rises in a roughly proportional fashion. This relationship holds for both people who form stones and people who do not.7PubMed. Calcium urolithiasis, blood pressure and salt intake The kicker is that stone formers excrete more calcium than non-stone-formers at every level of sodium intake, so salt does more damage if you are already prone to stones.
This means a person eating a high-sodium diet is simultaneously raising their blood pressure and loading their urine with extra calcium. It is one of the clearest lifestyle habits that fuels both conditions at once. Population data confirms the overlap: a 100 mmol higher daily sodium excretion predicted about 1 mmol more daily urinary calcium, independent of blood pressure effects.4Journal of Human Hypertension. Urinary calcium excretion, sodium intake and blood pressure in a multi-ethnic population: results of the Wandsworth Heart and Stroke Study Cutting back on salt is one of the few interventions that genuinely targets both your blood pressure and your stone risk simultaneously.
Randall’s Plaques and Vascular Damage Inside the Kidney
Most calcium kidney stones do not form floating freely in urine. They grow on tiny calcium deposits embedded in the inner surfaces of the kidney, called Randall’s plaques. Researchers have long tried to figure out why some people develop more of these plaques than others, and hypertension keeps surfacing as a key factor. A high-resolution radiography study of cadaveric kidneys found that a history of hypertension was the only clinical factor that correlated with papillary calcifications, the early deposits that become Randall’s plaques.8PubMed. High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation
The vascular theory of plaque formation helps explain why. The inner tips of the kidney (the papillae) exist in an environment that is naturally low in oxygen, highly concentrated in salt, and subject to turbulent blood flow. Together, these conditions make the blood vessels in this region vulnerable to injury.9PubMed. Vascular theory of the formation of Randall plaques Hypertension adds to that injury by chronically increasing the pressure on these tiny vessels, accelerating the process of calcium deposition in and around them. Once a plaque forms, it becomes a seed on which a full stone can grow when urine conditions are right.
Oxidative Stress and the Angiotensin Pathway
One of the more interesting mechanistic stories involves the renin-angiotensin system, the hormone pathway that helps regulate blood pressure. When this system is overactive, as it often is in hypertension, it drives up levels of angiotensin II, a molecule that not only constricts blood vessels but also promotes oxidative stress in kidney cells. Cell and animal studies show that exposure to calcium oxalate crystals activates this same angiotensin pathway in the kidney, ramping up production of reactive oxygen species and inflammatory molecules that make it easier for crystals to stick and grow.10PubMed Central. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?
This finding has a practical implication. In lab studies, losartan, a blood pressure drug that blocks the angiotensin receptor, reduced the expression of proteins involved in stone formation and decreased crystal deposition in kidney cells exposed to calcium oxalate.11PubMed Central. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress This is still early-stage evidence from cell culture and animal work, not proof that taking losartan will prevent your kidney stones. But it shows the biology is interconnected in a way that is not just statistical coincidence.
Metabolic Syndrome and the Bigger Cluster of Risk
Hypertension rarely travels alone. It tends to cluster with insulin resistance, obesity, and abnormal blood lipids in a pattern known as metabolic syndrome, and each of these conditions independently nudges the kidneys toward stone formation. Insulin resistance drives urine pH lower by impairing the kidney’s ability to excrete acid. It also reduces urinary citrate, the natural stone inhibitor mentioned earlier. And the compensatory spike in insulin that comes with insulin resistance can itself increase calcium excretion.12PubMed Central. Metabolic syndrome and nephrolithiasis
Obesity contributes through a different route: it disrupts vitamin D metabolism and promotes chronic inflammation, which can throw off the body’s calcium-phosphate balance. Hypertension then adds its own contribution, further reducing urinary citrate levels and promoting the calcium leak described above.13PubMed Central. Association of insulin resistance indices with kidney stones and their recurrence in a non-diabetic population: an analysis based on NHANES data from 2007–2018 The practical takeaway is that if you have hypertension plus insulin resistance or obesity, your kidney stone risk is being amplified from multiple directions at once. Addressing only one piece of the metabolic picture leaves the other risk factors running unchecked.
Which Blood Pressure Medications Help (or Don’t)
If you take medication for high blood pressure, the type of drug matters for your stone risk. Thiazide diuretics have a unique dual benefit: they lower blood pressure through their effects on sodium and blood vessel relaxation, and they also reduce the amount of calcium the kidneys dump into the urine.14PubMed. Effects of thiazides and new findings on kidney stones and dysglycemic side effects Thiazides have been used for decades to prevent recurrent kidney stones in people who form calcium-based stones, so if you need blood pressure treatment and have a history of stones, they pull double duty.
A retrospective study of adults over 65 compared the stone risk associated with different blood pressure drug classes, using beta-blockers as the reference group. Thiazides were associated with a roughly 24% lower risk of developing kidney stones. ACE inhibitors and ARBs showed a borderline benefit in initial analysis, but the protective effect disappeared when researchers looked specifically at stones requiring surgical intervention. Calcium channel blockers showed no difference in stone risk at all.15PubMed. Antihypertensive medications and the risk of kidney stones in older adults: a retrospective cohort study This does not mean you should switch medications on your own, but it is worth discussing with your doctor if recurrent stones are a concern alongside hypertension.
Can Kidney Stones Cause High Blood Pressure?
The relationship is not strictly one-directional. There is some evidence that kidney stone disease, or at least certain treatments for it, can push blood pressure upward. A nationwide cohort study found that patients who underwent shock wave lithotripsy, a common non-invasive stone treatment that uses focused sound waves to break stones apart, had a 20% higher risk of developing new-onset hypertension compared with patients treated by a scope-based technique. The risk increased with more lithotripsy sessions.16PubMed. Increased Risk of New-Onset Hypertension After Shock Wave Lithotripsy in Urolithiasis: A Nationwide Cohort Study The mechanism likely involves repetitive micro-injury to the kidney tissue and its blood vessels from the shock waves themselves.
Separately, the metabolic abnormalities that cause kidney stones, such as chronic low-grade inflammation, oxidative stress, and disordered calcium handling, may themselves contribute to cardiovascular changes over time. So while the evidence is clearest for hypertension driving stone risk, the two conditions can reinforce each other in a feedback loop, especially in people with underlying metabolic syndrome.
Dietary Patterns That Target Both Conditions
Because hypertension and kidney stones share some of the same dietary triggers, certain eating patterns can address both at once. The DASH diet, originally designed to lower blood pressure through emphasis on fruits, vegetables, whole grains, and low-fat dairy with limited sodium and red meat, turns out to have favorable effects on urinary stone chemistry as well. People who follow a DASH-style pattern tend to have higher urinary citrate, higher urine volume, and lower supersaturation of uric acid, all of which reduce stone risk.17PubMed Central. DASH-style diet and 24-hour urine composition
The potassium and magnesium in fruits and vegetables alkalinize the urine and boost citrate excretion. The dairy provides calcium, which might seem counterintuitive, but dietary calcium actually binds oxalate in the gut and prevents it from reaching the kidneys. And of course, the low sodium content of DASH directly limits urinary calcium losses. If there is a single lifestyle change that targets both conditions, reducing sodium intake while eating more produce and moderate dairy is probably it.
Obstructive Sleep Apnea and an Underappreciated Overlap
One condition that quietly links hypertension and kidney stones is obstructive sleep apnea. OSA is already one of the most common secondary causes of high blood pressure. But research also suggests it may independently increase stone risk. A study using NHANES data found that people with OSA had about a 29% higher prevalence of kidney stones after adjusting for confounders, and Mendelian randomization analysis suggested the connection might be causal.18PubMed Central. Link Between Obstructive Sleep Apnea and Kidney Stones: NHANES 2015–2018 and Mendelian Randomization
The proposed mechanism involves the repeated drops in oxygen and surges in stress hormones that occur with each apnea episode overnight. These fluctuations drive up blood pressure, promote insulin resistance, and may alter urinary acid excretion, all of which circle back to stone formation. If you have been diagnosed with both hypertension and recurrent kidney stones, and you also snore heavily or feel exhausted despite enough sleep, getting screened for OSA could address an upstream cause of both problems.
The Urinary Microbiome Angle
An emerging area of research looks at the bacterial communities that inhabit the urinary tract. Urine was once thought to be sterile, but sequencing studies have revealed it has its own microbiome. A study comparing the urinary bacteria of kidney stone patients with and without hypertension found striking differences. Healthy controls had a predominance of Gardnerella in their urinary microbiome, while stone patients without hypertension had Staphylococcus-dominant communities, and stone patients with elevated blood pressure had communities dominated by Sphingomonas. The abundance of several bacterial genera correlated with blood pressure levels.19Journal of Translational Medicine. Characteristics of the urinary microbiome in kidney stone patients with hypertension
This research is still in its early stages and does not yet tell us whether the microbial changes are a cause of stones, a consequence, or a bystander effect of the altered urinary chemistry that comes with hypertension. But it opens a future possibility: if certain bacterial communities promote or inhibit crystal formation, interventions that shift the urinary microbiome could become part of stone prevention strategies. For now, the finding is mainly a reminder that the biology connecting blood pressure and stones runs deeper than a shared risk factor list.